Anteris Technologies (AU:AVR) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Anteris Technologies has announced the redemption of convertible notes held by Obsidian Global Partners. The company, known for its innovative medical devices like the DurAVR Transcatheter Heart Valve, continues to make strides in treating aortic stenosis with its biomimetic valve technology. This development reflects Anteris’ ongoing commitment to advancing structural heart disease solutions.
For further insights into AU:AVR stock, check out TipRanks’ Stock Analysis page.